<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">The primary objective is to compare the effect of azithromycin in participants with a clinical diagnosis of COVID-19 in reducing the proportion with either death or hospital admission with respiratory failure requiring invasive or non-invasive mechanical ventilation over 28â€‰days from randomisation.</p>
